TAKE Solutions reported a 15 per cent decline in net profit to ₹46 crore for the quarter ended June 30, compared with ₹54 crore in the corresponding quarter last year. Revenue increased by 25 per cent to ₹583 crore (₹468 crore). During the quarter, two of the top five pharma companies renewed long-term multi-million-dollar contracts till 2022. “We are on track in terms of our vision to be a $500 million enterprise by 2021,” said HR Srinivasan, Vice-Chairman and Managing Director, TAKE Solutions, in a press release.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.